Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Cressman who wrote (2549)	2/2/2000 3:51:00 PM
From: Walter Morton	Read Replies (1) of 2742

Phil, have you sold all of your CIST? Does that previous post give you the impression that CIST has made some progress regarding CIST's agreement with Pasteur Meriux Connaught, a subsidiary of Aventis (NYSE:AVE)(formerly known as Rhone-Pouleno Group (NYSE: RP))? The merger of France's Rhone-Poulenc and Germany's Hoechst created Aventis and displaced Merck as the #1 pharmaceutical company in terms of revenue: cbs.marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next